Progress Being Made With Cell And Gene Therapy Market Access, But Challenges Remain

 
• By Mandy Jackson
Drugs in capsules, DNA and medicine, 3d rendering - Illustration
Payers see value in gene therapies, but capacity for mutiple products is limited. • Source: Shutterstock

More from Drug Pricing

More from Scrip